Literature DB >> 10631932

Antigen processing and presentation--towards the millennium.

G J Hämmerling1, A B Vogt, H Kropshofer.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10631932     DOI： 10.1111/j.1600-065x.1999.tb01351.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  7 in total

Review 1.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 2.  Advances in the study of HLA-restricted epitope vaccines.

Authors:  Lingxiao Zhao; Min Zhang; Hua Cong
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

3.  Marrow-derived CD40-positive cells are required for mice to clear Cryptosporidium parvum infection.

Authors:  A R Hayward; M Cosyns; M Jones; E M Ponnuraj
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  Analysis and prediction of affinity of TAP binding peptides using cascade SVM.

Authors:  Manoj Bhasin; G P S Raghava
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

5.  Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.

Authors:  Dan Laheru; Barbara Biedrzycki; Elizabeth M Jaffee
Journal:  Methods Mol Biol       Date:  2013

Review 6.  Development of Peptide Vaccines in Dengue.

Authors:  Kavita Reginald; Yanqi Chan; Magdalena Plebanski; Chit Laa Poh
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

7.  Enhancement of Tetravalent Immune Responses to Highly Conserved Epitopes of a Dengue Peptide Vaccine Conjugated to Polystyrene Nanoparticles.

Authors:  Yanqi Chan; Seyed Davoud Jazayeri; Babu Ramanathan; Chit Laa Poh
Journal:  Vaccines (Basel)       Date:  2020-07-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.